نتایج جستجو برای: paromomycin

تعداد نتایج: 482  

2014
Joanna Panecka Cameron Mura Joanna Trylska

The conformational properties of the aminoacyl-tRNA binding site (A-site), and its surroundings in the Escherichia coli 30S ribosomal subunit, are of great relevance in designing antibacterial agents. The 30S subunit A-site is near ribosomal protein S12, which neighbors helices h27 and H69; this latter helix, of the 50S subunit, is a functionally important component of an intersubunit bridge. E...

Journal: :Genetics 1975
G H Rank A J Robertson K L Phillips

A meiotic segregant (oliPR1) was isolated with a phenotype of multiple cross resistance and collateral sensitivity. Strain oliPR1 has increased sensitivity to ethidium bromide, dequalinium chloride, acriflavin, paromomycin and neomycin, and increased resistance to oligomycin, rutamycin, venturicidin, triethyltin bromide, antimycin, carbonylcynamide-m-chlorophenylhydrazone, tetra-N-butylammonium...

2012
Joline Goossens Frank Pasmans Elin Verbrugghe Virginie Vandenbroucke Siegrid De Baere Evelyne Meyer Freddy Haesebrouck Patrick De Backer Siska Croubels

BACKGROUND The gastrointestinal tract is the first target for the potentially harmful effects of mycotoxins after intake of mycotoxin contaminated food or feed. With deoxynivalenol (DON), T-2 toxin (T-2), fumonisin B1 (FB1) and zearalenone (ZEA) being important Fusarium toxins in the northern hemisphere, this study aimed to investigate in vitro the toxic effect of these mycotoxins on intestinal...

2015
Kazi M. Jamil Rashidul Haque Ridwanur Rahman M. Abul Faiz Abu Toha Md. Rezwanul Haque Bhuiyan Amresh Kumar Syed Misbah Hassan Heather Kelly Pritu Dhalaria Sonali Kochhar Philippe Desjeux Mohammad A. A. Bhuiyan Mohammed M. Khan Raj Shankar Ghosh Diana N. J. Lockwood

BACKGROUND This study was conducted in Bangladeshi patients in an outpatient setting to support registration of Paromomycin Intramuscular Injection (PMIM) as a low-cost treatment option in Bangladesh. METHODOLOGY This Phase IIIb, open-label, multi-center, single-arm trial assessed the efficacy and safety of PMIM administered at 11 mg/kg (paromomycin base) intramuscularly once daily for 21 con...

Journal: :BMJ case reports 2017
Thomas Roland Halil Yildiz Bernard Vandercam Lucie Pothen

Roland T, et al. BMJ Case Rep 2017. doi:10.1136/bcr-2017-221254 Description A 39-year-old patient was admitted to our hospital for 10 days fever (up to 40°C) with pain in the right hypochondrium. Abdominal echography performed at the onset of symptoms was normal. Blood tests showed C-reactive protein 311 mg/L, leucocytes count 24x10 /L (neutrophils count at 19, 29x10/L), bilirubin 1.1 mg/dL, la...

2010
Filip Meheus Manica Balasegaram Piero Olliaro Shyam Sundar Suman Rijal Md. Abul Faiz Marleen Boelaert

BACKGROUND Visceral leishmaniasis is a systemic parasitic disease that is fatal unless treated. We assessed the cost and cost-effectiveness of alternative strategies for the treatment of visceral leishmaniasis in the Indian subcontinent. In particular we examined whether combination therapies are a cost-effective alternative compared to monotherapies. METHODS AND FINDINGS We assessed the cost...

Journal: :Antimicrobial agents and chemotherapy 2005
Xiaomin Cai Keith M Woods Steve J Upton Guan Zhu

We report here on a quantitative real-time reverse transcription-PCR (qRT-PCR) assay for assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum. The qRT-PCR assay detects 18S rRNA transcripts from both parasites, that is, the cycle threshold for 18S rRNA from parasites (C(T)([P18S])) and host cells (C(T)([H18S])), and evaluates the relative expression between parasite...

2010
Asrat Hailu Ahmed Musa Monique Wasunna Manica Balasegaram Sisay Yifru Getahun Mengistu Zewdu Hurissa Workagegnehu Hailu Teklu Weldegebreal Samson Tesfaye Eyasu Makonnen Eltahir Khalil Osama Ahmed Ahmed Fadlalla Ahmed El-Hassan Muzamil Raheem Marius Mueller Yousif Koummuki Juma Rashid Jane Mbui Geoffrey Mucee Simon Njoroge Veronica Manduku Alice Musibi Geoffrey Mutuma Fredrick Kirui Hudson Lodenyo Dedan Mutea George Kirigi Tansy Edwards Peter Smith Lawrence Muthami Catherine Royce Sally Ellis Moses Alobo Raymond Omollo Josephine Kesusu Rhoda Owiti John Kinuthia

BACKGROUND Visceral leishmaniasis (VL) is a major health problem in developing countries. The untreated disease is fatal, available treatment is expensive and often toxic, and drug resistance is increasing. Improved treatment options are needed. Paromomycin was shown to be an efficacious first-line treatment with low toxicity in India. METHODS This was a 3-arm multicentre, open-label, randomi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید